echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Urinary System > Clinical necessity Treatment and management of erectile dysfunction

    Clinical necessity Treatment and management of erectile dysfunction

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Guide

    Erectile dysfunction (ED) is a common sexual dysfunction in which a man cannot consistently obtain and maintain enough penile erections to complete a satisfying sex life
    .
    ED is a chronic condition that has a serious impact on physical and mental health and has a significant impact on the quality of life of patients and their partners; At the same time, ED is also an early warning sign
    of other chronic diseases (especially cardiovascular disease, CVD).
    Active ED diagnosis and treatment can help detect or prevent chronic diseases
    such as CVD and diabetes early.
    In order to standardize the diagnosis and treatment process of ED and provide reference for clinicians, the Andrology Branch of the Chinese Medical Association has compiled the "Guidelines for the Diagnosis and Treatment of Erectile Dysfunction", in which the main points of the treatment and management part are organized as follows
    .





    Treatment of ED


    The etiology and pathogenesis of ED are complex, not only related to local lesions of the penis, but also closely
    related to various chronic diseases.
    The ultimate goal of ED treatment is to improve penile erectile function, increase sexual satisfaction and quality of life for both partners, while delaying the progression of ED and preventing the progression of
    comorbid diseases.


    While focusing on controlling the causes, reducing risk factors and symptomatic treatment, ED treatment should also follow overall health management, chronic disease management, and physical and mental treatment and the principle of
    co-governance.


    Basic treatment


    ED may be a prodromal symptom and local manifestation of systemic diseases, and the effective management of underlying diseases, poor lifestyle and mental and psychological factors associated with ED patients, especially basic treatment, will inevitably be conducive to the rehabilitation
    of ED.


    1.
    A good lifestyle is important for improving erectile function
    .
    Moderate exercise, reasonable diet, good sleep, weight control, etc.
    can improve vascular function and erectile function, and can increase the effect of drug treatment, such as phosphodiesterase inhibitor type 5 (PDE5i) to improve
    erectile function.


    2.
    For patients with clear underlying diseases, ED should be treated before or at the same time as ED, such as CVD, diabetes, hyperlipidemia, depression, etc.
    , and attention should also be paid to some antihypertensive drugs, lipid-lowering drugs, and antidepressants that may cause ED
    for the treatment of these underlying diseases.


    3.
    People with ED are more likely to have psychological problems
    such as reduced happiness, self-confidence and self-esteem.
    Sex education, counseling, psychological counseling and treatment for patients can help restore their sexual function
    .


    4.
    People with ED should be made to understand that sex is an important part of quality of life and to face this problem
    with their sexual partners.
    Close sexual partner feelings (especially passion) is the first concern, appropriately mobilize the interest of patients and their partners in sexual life, and encourage them to appropriately increase the frequency of sexual life under psychological or drug treatment, and gradually learn sexual life skills
    .


    Oral drug therapy


    Oral PDE5i has become the preferred treatment of ED, and is easy to accept by most patients because it is convenient, safe and effective
    .
    PDE5i has two modes
    : on-demand use and regular use.


    Androgen replacement therapy


    Patients with primary or secondary male hypogonadism for various causes often have ED, and androgen therapy in such patients can not only enhance libido, but also improve erectile function
    .
    In patients with ED with low testosterone levels, androgen replacement therapy improves erectile function in people who do not respond to PDE5i for the first time, and may have a potentiating effect
    when combined with PDE5i.


    Antioxidants and drugs that improve microcirculation


    With age, as well as some metabolic diseases such as diabetes, the body is mostly in a state of oxidative stress, resulting in a decrease in NO and an increase in vascular endothelin 1 (ET-1), causing a weakening of smooth muscle relaxation and contractility of the corpus cavernosum, and causing functional and organic damage to the blood endothelium of small blood vessels, thereby aggravating the degree of ED.


    Other drugs


    Other drugs such as apomorphine, trazodone and other drugs have been partially confirmed for ED, but their use is less
    .


    physiotherapy


    Physiotherapy (such as negative pressure aspiration and micro-energy) is often used as an adjunct to ED therapy, and appropriate physiotherapy
    may be selected or combined with patients who do not respond well to oral drugs alone.
    Commonly used physiotherapy methods include
    vacuum erection device (VED), low-intensity extracorporeal shockwave therapy (LI-ESWT), low-intensity pulsed ultrasound (LIPUS), electrophysiological techniques, etc
    .


    Penile cavernous body injection (ICI) treatment


    ICI therapy as a second-line regimen for ED may be considered
    when oral medications are ineffective.
    Commonly used drugs include prostaglandin E1, papaverine, phentolamine, etc.
    , often using combination therapy, aiming to improve the efficacy while reducing the adverse reactions
    of each drug.
    At present, the combined application of papaverine, prostaglandin E1 and phentolamine has the highest effective rate, up to 92%.


    Transurethral administration


    Transurethral vasoactive drugs are mainly based on the consideration of reducing penile trauma, and the commonly used drug is alprostadil.

    There are two different methods of administration: the first is a mixture made with a cream that promotes osmotic action, applied to the external urethral orifice to facilitate the absorption of alprostadil, the clinical use of which has very limited
    data.
    The second method of administration is to place the alprostadil preparation into the urethra, and 30% to 65.
    9% of patients can obtain enough erection for sexual intercourse
    .


    Surgical treatment


    Surgery is the third-line treatment for ED and is used in patients
    with moderate to severe ED who do not respond to first- and second-line treatments.
    Due to the poor long-term efficacy of penile vascular surgery, surgical indications should be strictly selected and adequate preoperative communication
    should be carried out.
    In the absence of contraindications, penile prosthesis surgery has good safety and efficacy, but attention should still be paid to prevent the occurrence
    of intraoperative and postoperative complications.


    Traditional Chinese medicine treatment


    Traditional Chinese medicine calls the disease "Yin Hemorrhage", "Tendon Hemorrhage", "Yin Apparatus Not Used", and the name "Impotence" began at the end of the Ming Dynasty, which has been used to this day
    .
    Traditional Chinese medicine treats impotence, emphasizing the overall concept and dialectical treatment, according to different symptom types, while enhancing erectile function and improving systemic symptoms
    .
    Modern research on the mechanism of action of impotence in traditional Chinese medicine mainly focuses on regulating the hypothalamic-pituitary-gonadal axis, improving microcirculation, anti-aging, and antioxidant
    .


    Treatment of special types of ED


    The consensus of the guidelines proposes detailed treatment options for the treatment of special types of ED, such as ED after pelvic surgery, ED after pelvic fracture, urethral injury (PFUI), ED after spinal cord injury (SCI), ED secondary to hyperprolactinemia, and ED after brain disease, as detailed in the original article
    .

     

    Figure 1 Treatment flow of ED




    Health management of ED


    ED health management is aimed at preventing and controlling the occurrence and development of ED and related diseases, reducing medical burden, and improving the quality of life, conducting health education for individuals and groups, improving self-management awareness and level, and aiming to mobilize the enthusiasm of individuals, collectives and society, and effectively use limited resources to achieve the greatest health effect
    .


    The health management of ED first needs to establish the patient's health file
    based on the patient's basic information, lifestyle, sexual life status, mental and psychological condition, health examination data, disease history, etc.
    Secondly, clinicians need to collect and track various information reflecting personal physical health, analyze and establish the quantitative relationship between lifestyle, sex frequency, environment, genetics, psychology, serum indicators, chronic diseases and other risk factors and ED, and use predictive models to determine participants' current health status and the development trend of ED, so that participants can understand whether there is a risk of ED and related chronic diseases
    .


    References

    1.
    Guidelines for the diagnosis and treatment of erectile dysfunction[J].
    Chinese Journal of Andrology,2022,28(08):722-755.
    )


    Editor: Gardenia Reviewed: Rudolf Executive: Rudolf


    This platform is designed to deliver more medical information
    to healthcare professionals.
    The content published on this platform cannot replace professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice
    .
    If such information is used for purposes other than understanding medical information, this platform does not assume relevant responsibilities
    .
    The content published by this platform does not mean that it agrees with its description and views
    .
    If copyright issues are involved, please contact us and we will deal with
    it as soon as possible.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.